Internal Medicine, Pulmonary Disease · New Haven, CT
NPI
1215143953
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
136 Sherman Ave Ste 302
New Haven, CT, 06511
Phone (203) 745-5660
Groups this clinician bills Medicare through
Medicare paid, 2024
$207K
2,921 services
Medicare patients, 2024
751
Average age 77
Drug cost, 2024
$5.8M
11,297 prescriptions
Company payments, 2025
$1,439
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kaiser Toosy was code 99213 (office e&m - established), 1,048 times for 573 patients. In total Kaiser Toosy billed 2,921 services in 25 codes, and Medicare paid $207K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,048 | 573 | $68.85 | $72K |
| 94060 Pulmonary Function Testing | Office | 384 | 332 | $31.12 | $12K |
| 94729 Pulmonary Function Testing | Office | 258 | 223 | $47.07 | $12K |
| 94727 Pulmonary Function Testing | Office | 257 | 222 | $36.42 | $9,361 |
| 99214 Office E&M - Established | Office | 248 | 190 | $98.59 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 196 | 66 | $95.43 | $19K |
| 99442 Telephone Services | Office | 116 | 71 | $64.83 | $7,520 |
| 99204 Office E&M - New | Office | 87 | 87 | $127.52 | $11K |
| 99291 Critical Care E&M | Facility | 66 | 27 | $171.12 | $11K |
| 99223 Hospital E&M - Initial | Facility | 55 | 42 | $139.23 | $7,658 |
| 99215 Office E&M - Established | Office | 54 | 47 | $145.74 | $7,870 |
| 99205 Office E&M - New | Office | 39 | 39 | $180.79 | $7,051 |
| 94618 Pulmonary Function Testing | Office | 35 | 33 | $26.39 | $924 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $33.90 | $542 |
| 90662 Vaccine Product | Office | 16 | 16 | $81.82 | $1,309 |
By year: 2022 $214K for 4,113 services; 2023 $217K for 3,284 services; 2024 $207K for 2,921 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kaiser Toosy prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 2,514 prescriptions and refills. In total Kaiser Toosy wrote 11,297 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 2,514 | 3,580 | 466 | $2.3M |
| Montelukast Sodium Generic | 1,151 | 3,318 | 345 | $15K |
| Prednisone Generic | 992 | 1,315 | 386 | $3,986 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 992 | 1,154 | 263 | $22K |
| Breo Ellipta Fluticasone/Vilanterol | 736 | 970 | 160 | $379K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 345 | 424 | 60 | $267K |
| Fluticasone Propionate Generic | 306 | 610 | 123 | $4,638 |
| Doxycycline Hyclate Generic | 284 | 284 | 228 | $2,181 |
| Symbicort Budesonide/Formoterol Fumarate | 266 | 351 | 91 | $78K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 258 | 322 | 94 | $48K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 254 | 337 | 69 | $38K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 204 | 251 | 54 | $16K |
| Azithromycin Generic | 193 | 292 | 58 | $1,796 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 172 | 238 | 38 | $107K |
| Azelastine Hcl Generic | 144 | 239 | 56 | $2,545 |
Brand drugs: 6,296 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kaiser Toosy $1,439 ($1,439 in general payments such as food, travel and fees) from 11 companies. The largest payer was GlaxoSmithKline, LLC. with $605.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 48 | $605 |
| Amgen Inc. AMGN | 14 | $217 |
| Philips North America LLC PHG | 9 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $89.65 |
| Genzyme Corporation SNY | 3 | $85.42 |
| Insmed, Inc. INSM | 3 | $78.68 |
| Verona Pharma, Inc. VRNA | 3 | $62.03 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $42.02 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $32.63 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $23.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.